Cargando…
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors
Chronic myeloid leukemia (CML) is characterized by a Philadelphia chromosome which contains an oncogene, bcr-abl. This oncogene encodes a tyrosine kinase which is constitutively activated. Imatinib, a tyrosine kinase inhibitor (TKI), has been widely used in the treatment of CML. Dasatinib and niloti...
Autores principales: | Huang, Xuan, Patel, Samir, Ahmed, Nasir, Seiter, Karen, Liu, Delong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761170/ https://www.ncbi.nlm.nih.gov/pubmed/19920908 |
Ejemplares similares
-
Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
por: Masago, Katsuhiro, et al.
Publicado: (2018) -
Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
por: Park, Sook Ryun, et al.
Publicado: (2016) -
Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity
por: Musolino, Caterina, et al.
Publicado: (2015) -
Bullous Skin Rash: A Rare Case of Palbociclib-Induced Dermatological Toxicity
por: Khan, Noman Ahmed Jang, et al.
Publicado: (2020) -
Diarrhea, negative t-waves, fever and skin rash, rare manifestation of carbamazepine hypersensitivity: a case report
por: Aigner, Felix, et al.
Publicado: (2008)